Stage 4 Mesothelioma
Stage 4 pleural mesothelioma is an advanced-stage asbestos cancer that has spread to distant parts of the body. The 5-year relative survival rate for patients is 11%. Immunotherapy and surgery-based treatment have improved survival for some stage 4 patients. Palliative care can also help improve quality of life.
Learn More About Stage 4 Mesothelioma in Our Free Guide Learn About Stage 4 Mesothelioma in Our Free Guide
What Is Stage 4 Mesothelioma?
Stage 4 mesothelioma is the most advanced stage of the asbestos-related cancer. Mesothelioma cancer begins when tumors develop in the linings of organs. The most common form develops in the lining around the lungs. In stage 4 mesothelioma, the cancer has spread (metastasized) to distant lymph nodes, organs and tissues. This can include the liver and both lungs.
- Distant cancer spread: Stage 4 mesothelioma has spread beyond nearby tissues and lymph nodes to distant parts of the body.
- Symptoms may become more severe: Patients may experience increased pain, breathing difficulties, fatigue and other symptoms in stage 4 mesothelioma.
- Treatment options remain available: In advanced stages of mesothelioma, immunotherapy, chemotherapy, radiation and clinical trials may help control the cancer, manage symptoms and extend survival.
- Palliative care can help: Pain management can relieve symptoms, reduce discomfort and improve quality of life in stage 4 mesothelioma.
- Survival can vary: How long someone lives with stage 4 mesothelioma varies from person to person and may depend on factors such as treatment response, cell type and overall health.
Mesothelioma staging describes how far cancer has spread and helps doctors determine which treatments may be appropriate. Stage 4 is the most advanced stage of mesothelioma and generally indicates that cancer has spread beyond the area where it first developed.
Mesothelioma is categorized into four stages based upon the amount and location of tumors.
The distant spread of stage 4 mesothelioma may limit some treatment options. But many effective methods, like surgery and chemotherapy, can be used in this stage. Some new and emerging treatments have also increased potential options for late-stage patients. For instance, stage 4 mesothelioma patients have benefitted from immunotherapy in various studies.
Some advanced stage patients may prefer to receive palliative care rather than aggressive treatment. These care plans focus on improving patient comfort and managing symptoms instead of shrinking tumors.
Patients may choose palliative care out of concern about severe treatment side effects. But recent advances may allow patients to prioritize comfort and quality of life while shrinking tumors. For example, checkpoint inhibitors may boost quality of life and improve survival.
What to Expect With Stage 4 Mesothelioma
What to expect with stage 4 mesothelioma can vary from person to person. After a biopsy confirms mesothelioma and imaging tests help determine how far the cancer has spread, doctors develop an individualized treatment plan based on factors such as mesothelioma type, tumor location, overall health and treatment goals. The patient journey below shows how a stage 4 diagnosis may lead to supportive, active or multimodal treatment.
For many patients, stage 4 mesothelioma treatment focuses on slowing cancer growth, managing symptoms and maintaining quality of life. Treatment plans may change over time based on how the cancer responds and the patient’s needs. A mesothelioma specialist can help patients understand which treatments are appropriate for their individual diagnosis, including whether they may qualify for immunotherapy, chemotherapy, a clinical trial or other specialized care.
Stage 4 Mesothelioma Symptoms
Patients with stage 4 mesothelioma may experience general symptoms of the disease like fatigue or fluid buildup. These symptoms may worsen if the tumors spread.
- Abdominal pain
- Chest pain
- Difficulty swallowing (dysphagia)
- Fatigue
- Fever
- Night sweats
- Peritoneal effusion (fluid buildup)
- Pleural effusion (fluid buildup)
- Shortness of breath (dyspnea)
- Unexplained weight loss
*List is a combination of common pleural, peritoneal, pericardial and testicular symptoms
Palliative treatment options may be able to help manage discomfort from mesothelioma symptoms. For example, one common palliative treatment drains fluid that has built up around the lungs. This can help ease breathing difficulties caused by the fluid.
Stage 4 Mesothelioma Cancer by Type
A mesothelioma patient’s tumor location has a strong influence on their individual experience. For example, pleural mesothelioma tumors form in the lining around the lungs. In advanced stages, pleural tumors might spread to both lungs.
Peritoneal mesothelioma patients may not have the same experience because their tumors develop in the lining of the abdomen. So peritoneal tumors might spread to abdominal organs, such as the intestines.
Tumor location can also affect survival, symptoms and treatment. By working with a mesothelioma doctor, patients can understand what to expect.
Stage 4 Pleural Mesothelioma
Over the years, doctors have established and improved different staging systems. These systems allow doctors to assess how early or advanced an individual case may be. An effective staging system can help oncologists choose the best treatment for their patients.
Of the various systems, the tumor node metastasis (TNM) staging system is the most common. Doctors typically use the TNM staging system to evaluate cases of pleural mesothelioma.
With stage 4 mesothelioma, the cancer has spread to distant parts of the body. This spreading of cancer, called distant metastasis, may affect the:
- Bones
- Distant organs or lymph nodes
- Liver
- Lung that did not have the initial tumor
These rates come from a 2012 analysis of the International Association for the Study of Lung Cancer (IASLC) mesothelioma database. About 52% of patients with stage 4 pleural mesothelioma were alive at one year and about 24% at two years.
Stage 4 Peritoneal Mesothelioma
There is no staging system specifically for peritoneal mesothelioma, though the TNM system is still applicable. Mesothelioma doctors commonly use the Peritoneal Cancer Index (PCI) to stage this type.
This system divides the abdomen into nine distinct areas. Each area has a score based on the size of the tumor(s) in that area. Doctors add the scores to determine the stage. A PCI score between 31 and 39 is classified as T4, the most advanced tumor category. In the published peritoneal staging system, T4 disease groups into stage 3 rather than a separate stage 4.
At this stage, tumors have spread outside the immediate area of the peritoneum. Spreading may affect the:
- Chest wall
- Nearby lymph nodes throughout the abdominal cavity
- Other distant tissues and organs
Stage 4 Pericardial Mesothelioma
Like peritoneal mesothelioma, there is no formal staging system for pericardial mesothelioma. Oncologists may use general cancer staging guidelines to determine the stage at diagnosis.
Because this type is rare, doctors often detect it in later stages. As with other types, stage 4 pericardial mesothelioma has spread to distant areas of the body. Stage 4 pericardial mesothelioma may spread to the:
- Abdomen
- Chest cavity
- Esophagus
- Other organs and tissues outside of the pericardium (heart lining)
Survival rate for this type is not broken down by stage because it is an uncommon form of mesothelioma.
Stage 4 Testicular Mesothelioma
Testicular mesothelioma accounts for less than 1% of all mesothelioma cases. The disease’s rarity complicates the staging process for mesothelioma doctors. In general, doctors stage testicular mesothelioma based on the cancer’s spread to distant:
- Lymph nodes
- Organs
- Tissues
Once diagnosed, testicular mesothelioma patients and their doctors can discuss next steps. These may include staging, treatment and other supportive measures.
Did You Know?
Research indicates mesothelioma patients who undergo some form of treatment may live at least twice as long as those who do not receive treatment.
In a National Cancer Database study of 4,655 patients with unresected pleural mesothelioma, median survival was 10.4 months for those who received chemotherapy and 4.8 months for those who received supportive care alone. Treatment roughly doubled survival in that group.
Stage 4 Mesothelioma Treatment
In the past, treatments for stage 4 mesothelioma were relatively limited. Now, advances in research and drug development have opened up new possibilities. Because of these advances, some stage 4 patients may have almost as many options as stage 2 or 3 patients, including:
- Alternative therapies
- Cancer-directed surgery as part of a multimodal (combined) plan
- Chemotherapy
- Clinical trials
- Immunotherapy
- Multimodal therapy
- Palliative treatment
Surgery for Stage 4 Mesothelioma
A common misconception about stage 4 mesothelioma is that surgery is no longer an option. Recent studies show this is not always true for pleural or peritoneal mesothelioma. Stage 4 patients have participated in several studies that involved surgery-based treatment.
These studies included the following surgeries as part of a multimodal treatment plan:
- Pleurectomy/decortication (P/D): This is a common surgical procedure for pleural mesothelioma. P/D removes the lining around the lung (the pleura) and tumors or fibrous tissue from the surface of the lung. The procedure allows patients to keep both lungs but still removes cancerous tissue.
- Cytoreductive surgery (CRS): This is a common surgical procedure for peritoneal mesothelioma. CRS removes as much cancerous tissue as possible from the abdomen. Often, doctors combine CRS with a heated chemotherapy, called hyperthermic intraperitoneal chemotherapy (HIPEC).
Some patients may prefer milder treatments aimed at increasing comfort and managing symptoms. Palliative options for stage 4 mesothelioma include minor surgeries, such as:
- Paracentesis: This procedure removes fluid from the abdominal cavity. This can help ease feelings of bloating caused by the fluid buildup.
- Pleurocentesis/thoracentesis: This procedure removes excess fluid around the lungs (pleural effusion). A doctor uses a needle to drain fluid buildup, reducing pressure on the lungs. This can help patients breathe easier.
- Pleurodesis: This procedure treats excess fluid around the lungs (pleural effusion) with a different approach. It attempts to prevent fluid buildup by closing the space between layers of the pleura. If successful, this can help prevent breathing issues related to pleural effusion.
Palliative treatments are aimed at relieving symptoms and improving comfort rather than extending survival.
Immunotherapy for Stage 4 Mesothelioma
Immunotherapy is a newer treatment that has recently become a standard option for mesothelioma. This treatment helps the body identify and attack cancer cells. There are different types of immunotherapy treatments, like CAR T cells and checkpoint inhibitors. Checkpoint inhibitors have approval for treating mesothelioma, while CAR T-cell treatment for mesothelioma is still in trial stages.
Checkpoint Inhibitors for Stage 4 Mesothelioma
Checkpoint inhibitor drugs may be an option for stage 4 mesothelioma patients. These drugs help the immune system identify and attack tumor cells that could otherwise avoid detection.
One recent, important study treated mesothelioma with two checkpoint inhibitors. The study enrolled 605 patients with unresectable pleural mesothelioma, including patients with stage 4 disease. The drug combination of Opdivo® (nivolumab) and Yervoy® (ipilimumab) provided several notable benefits:
- Maintained quality of life: Opdivo + Yervoy delayed deterioration in quality of life compared with chemotherapy, roughly halving the risk of a definitive decline.
- Improved survival: Median overall survival was 18.1 months with Opdivo + Yervoy, compared with 14.1 months for chemotherapy.
Five-year follow-up published in 2026 found 14% of patients given Opdivo + Yervoy were still alive at five years, compared with 6% of those given chemotherapy.
Keytruda® (pembrolizumab) with chemotherapy is a second first-line option. The U.S. Food and Drug Administration approved this combination in September 2024 for unresectable advanced or metastatic pleural mesothelioma, which includes stage 4 disease.
In the KEYNOTE-483 trial, patients who received pembrolizumab with pemetrexed and platinum chemotherapy lived a median of 17.3 months. Those who received chemotherapy alone lived 16.1 months. Doctors weigh the two immunotherapy options against cell type, overall health and other treatments.
Combination Immunotherapy in Advanced Mesothelioma
Doctors have had success in treating advanced mesothelioma with combination immunotherapy treatments. One innovative trial treated pleural mesothelioma with CAR T-cell therapy and a checkpoint inhibitor called Keytruda.
The trial treated 27 patients, 25 of whom had pleural mesothelioma. Among the 18 who also received Keytruda, median overall survival was 23.9 months from the CAR T-cell infusion and 83% were alive at one year. Research continues to study the effectiveness of late-stage mesothelioma cancer treatments.
Multimodal Therapies for Stage 4 Mesothelioma
Some stage 4 patients may benefit from multimodal therapy, or combining various treatments. This is a common treatment choice for eligible patients. Depending on the stage, some treatment combinations may provide more benefits than others.
For stage 4 mesothelioma patients, doctors routinely combine these therapies:
- P/D + HITHOC: This multimodal treatment for pleural mesothelioma combines P/D surgery with heated chemotherapy. After surgery, doctors apply hot chemotherapy, called hyperthermic intrathoracic chemotherapy (HITHOC), to the pleural cavity. A 2026 meta-analysis of six studies and 1,060 patients found median survival of 21.3 months for patients who received HITHOC after cytoreductive surgery, compared with 18.8 months for surgery alone.
- CRS + HIPEC: This multimodal treatment for peritoneal mesothelioma combines CRS surgery with heated chemotherapy. After surgery, doctors apply HIPEC to the abdominal cavity. One study found stage 4 patients lived about 26 months after this treatment.
Peritoneal patients ineligible for CRS + HIPEC may receive pressurized intraperitoneal aerosol chemotherapy (PIPAC). At least one study found that repeated PIPAC therapy helped advanced-stage mesothelioma patients become eligible for CRS + HIPEC.
Multimodal therapy may now be more common among stage 4 patients than in the past. Patients should speak with an expert to understand all their options.
Chemotherapy for Stage 4 Mesothelioma
Doctors may use systemic chemotherapy to extend survival and improve quality of life. Some of the most common chemotherapy drugs for stage 4 patients are:
Doctors may also add bevacizumab, a targeted therapy, to chemotherapy. In the MAPS trial, patients on bevacizumab plus chemotherapy lived a median of 18.8 months. Those on chemotherapy alone lived 16.1 months.
Palliative Treatments for Stage 4 Mesothelioma
Palliative care can help relieve symptoms and improve quality of life for people with stage 4 mesothelioma. Depending on a patient’s needs, doctors may recommend procedures to drain fluid around the lungs or abdomen, radiation therapy to reduce pain, medications for symptom management or other supportive care. Palliative care can be provided alongside treatments such as immunotherapy or chemotherapy and does not necessarily mean a patient has stopped receiving cancer treatment.
Stage 4 Mesothelioma Clinical Trials
Stage 4 mesothelioma patients may qualify for clinical trials investigating promising new treatments or combinations of existing therapies. Many patients with advanced mesothelioma have participated in clinical trials evaluating new ways to control the cancer and improve outcomes.
Recent research includes the 2025 phase III BEAT-meso trial, which studied a new first-line treatment combination for advanced pleural mesothelioma. Patients who received atezolizumab with bevacizumab and chemotherapy went a median of 9.2 months before their cancer worsened, compared with 7.6 months for those receiving bevacizumab and chemotherapy alone. However, the improvement in overall survival did not reach statistical significance across the full study population.
Research continues in 2026. Active mesothelioma trials are investigating approaches including CAR T-cell therapy, targeted drugs and new treatment combinations. Patients and their doctors can discuss clinical trial eligibility and which trials may be a good fit for their treatment goals.
Alternative Therapies for Stage 4 Mesothelioma
Stage 4 mesothelioma patients may consider using alternative therapies alongside standard ones. Alternative treatments are not curative but aim to increase patients’ comfort and manage symptoms. Some alternative therapies can also help manage the side effects of traditional treatment.
Alternative therapies include herbal medicine, acupuncture and dietary supplements. Nutrition professionals and doctors can also explain what to include in a healthy cancer diet. Patients and their doctors can determine which alternative therapies may work with their diagnoses and other treatments.
Stage 4 Mesothelioma Prognosis
Many factors, including the stage of mesothelioma, can affect prognosis. Determining the stage helps doctors estimate prognosis and create a care plan. However, stage is not the only factor affecting prognosis.
Other factors, such as patient age and tumor location, can also impact prognosis. Doctors consider all factors when recommending treatments. For all stages, specialized treatment is the best way to improve a mesothelioma prognosis.
- Biological sex: Female patients tend to have better survival than male patients.
- Blood counts: Different blood characteristics may have a negative impact on survival. These include high platelet count, high white blood cell count and/or low hemoglobin.
- Cell type: Epithelioid mesothelioma tends to have better survival rates than sarcomatoid or biphasic.
- Overall health: Pre-existing conditions or poor overall health may have a negative impact on survival.
- Patient age: In general, younger patients tend to have better survival than older patients.
- Tumor location: In general, peritoneal mesothelioma survival is better than other types.
Statistics can help patients understand the typical progression of the disease. Still, each patient’s diagnosis is unique.
One example is the five-year follow-up of the CheckMate 743 trial, where 14% of patients treated with Opdivo + Yervoy were still alive five years after starting treatment.
Stage 4 Mesothelioma Life Expectancy and Survival Rates
Life expectancy for stage 4 mesothelioma varies based on several factors, including where mesothelioma develops in a patient’s body, the cancer’s cell type and the patient’s overall health and course of treatment. According to recent data from the National Cancer Institute’s (NCI) SEER database, the 5-year relative survival rate for distant pleural mesothelioma is 11%. Several treatment options have improved stage 4 mesothelioma survival in studies. Patients can discuss their individual life expectancy and mesothelioma treatment options with their doctors.
Stage 4 Pleural Mesothelioma Survival Statistics
In general, stage 4 pleural mesothelioma life expectancy is 12 months. With treatment, survival rates for stage 4 pleural mesothelioma are:
- 1-year: 52%
- 2-year: 24%
Recent advances show some forms of treatment may be better than others for stage 4 mesothelioma. Some treatments have been effective at extending life expectancy at this stage.
Examples of these treatments include checkpoint inhibitors and multimodal treatment plans. Multimodal plans are a combination of more than one treatment method.
Depending on treatment types, stage 4 malignant pleural mesothelioma life expectancies can vary.
| Treatment Type | Life Expectancy |
|---|---|
| Systemic Chemotherapy | 14.1 months |
| Checkpoint Inhibitor Immunotherapy | 18.1 months |
| Multimodal Treatment | 21.3 months |
| Pembrolizumab Plus Chemotherapy | 17.3 months |
| No Treatment* | 6 months |
*Life expectancy shown for no treatment applies to all pleural mesothelioma patients regardless of stage
Stage 4 Peritoneal Mesothelioma Survival Statistics
In general, stage 4 peritoneal mesothelioma life expectancy is 26 months with treatment. Survival rates for stage 4 peritoneal mesothelioma patients who undergo treatment are:
- 1-year: 63%
- 3-year: 40%
Many factors may influence individual life expectancy. For example, patients treated with surgery-based plans may live longer than those receiving just chemotherapy. Stage 4 peritoneal mesothelioma patients can discuss these factors, including treatment options, with their doctors. Patients may have many possible treatment options, including promising new methods.
Stage 4 Pericardial and Testicular Mesothelioma Survival Statistics
Pericardial mesothelioma and testicular mesothelioma are less common types of this cancer. Survival rates are not yet known for stage 4 pericardial and testicular mesothelioma. The infrequency of these types means research is limited. Also, unlike pleural and peritoneal mesothelioma, these types of cancer do not have established staging systems.
General survival times for these types of mesothelioma, regardless of stage, are approximately:
- Pericardial mesothelioma: 6 months
- Testicular mesothelioma: About 6 years overall, but closer to 2 years for patients with advanced disease
A specialist can help estimate the prognosis for a pericardial or testicular mesothelioma patient.
Locate a Mesothelioma Cancer Center Near You Find the right fit for your situation Get Connected
Can Stage 4 Mesothelioma Be Cured?
Stage 4 mesothelioma is generally not considered curable because the cancer has spread to distant areas of the body. However, treatment may help slow cancer growth, relieve symptoms and extend survival. Some patients respond well to treatments such as immunotherapy, chemotherapy or clinical trials and may live longer than the average life expectancy for this stage of the disease.
When patients hear Stage 4, they sometimes assume there is nothing more we can do. That isn’t necessarily the case. Treatments such as immunotherapy and chemotherapy may help control the cancer, and some patients may qualify for clinical trials. The important thing is to have an experienced mesothelioma team evaluate your individual diagnosis and discuss the options that make sense for you.
Francis Perry Wilson, MD
A mesothelioma specialist, as part of a multidisciplinary team, can recommend an individualized treatment plan for stage 4 mesothelioma based on factors such as cancer location, cell type, overall health and response to previous treatments. Beyond treatment decisions, patients and their loved ones may also benefit from resources and support to help manage the physical and emotional challenges of living with stage 4 mesothelioma.
Living With Stage 4 Mesothelioma
A stage 4 mesothelioma diagnosis can be emotional for patients and their loved ones. But informational and supportive resources are available to help navigate this journey. These resources may help manage emotional, mental and physical well-being while living with stage 4 mesothelioma.
Patients may feel overwhelmed by the medical information they are receiving. Mesothelioma specialists can offer guidance and help explain the details of a diagnosis. Patients can discuss any questions they have with their care team. This can help patients and their loved ones better understand their diagnoses.
Patients may also worry that their life expectancy is final and set in stone. But with treatment, many stage 4 patients have outlived their initial life expectancies. Mesothelioma survivor stories may encourage patients and their loved ones. Mesothelioma support groups can also provide comfort. Patients may find these groups through their cancer centers, doctors or online.
Each mesothelioma experience and decision is personal, including choices about what comes next. Stage 4 patients may choose to consider future preparations, too. There are many professionals who can guide them through these processes. Patients and their loved ones can find more resources about these topics below.
Resources for Final Stage Mesothelioma Patients: End-of-Life Planning and More
Dealing with end-stage mesothelioma can be daunting, but resources are available to improve quality of life and give patients peace of mind. Resources are also available for family members and caregivers.
- Connect With the Mesothelioma Community
- Learn How to Pay Medical Bills and Provide Financial Security for Loved Ones
- Learn More About End-of-Life Planning
Stage 4 mesothelioma patients and their loved ones have many options to support them. Visit our patient resources page to learn more about how we help mesothelioma patients.
Have a Question About Stage 4 Mesothelioma? Ask experienced mesothelioma advocate Jennifer Lucarelli Ask a Question
Common Questions About Stage 4 Mesothelioma
How is stage 4 mesothelioma different from earlier stages?
What are the treatment options for stage 4 mesothelioma?
Can stage 4 mesothelioma be cured?
Is stage 4 mesothelioma the same as end-stage mesothelioma?
What can patients with stage 4 mesothelioma expect?
Note: This page contains statistics gleaned from large groups of patients. These statistics cannot forecast a single patient’s risk, cancer experience or the success of any given treatment. Patients should discuss all cancer screening and treatment decisions with an experienced oncologist.
Sources
National Library of Medicine - Consensus Guideline for the Management of Peritoneal Mesothelioma; 6/1/2026
American Cancer Society - Survival Rates for Pleural Mesothelioma; 2/3/2026
National Cancer Institute - Malignant Mesothelioma Treatment (PDQ®)–Health Professional Version; 5/12/2025
ASCO Publications - Treatment of Pleural Mesothelioma: ASCO Guideline Update; 1/8/2025
Financial Assistance for Mesothelioma Patients
Dr. Francis Perry Wilson is the Director of the Clinical and Translational Research Accelerator at the Yale University School of Medicine. He specializes in nephrology and clinical research.
Medically
Reviewed by
James Stevenson, MD
Thoracic Medical Oncologist
Dr. James Stevenson is a Board-Certified Medical Oncologist. He specializes in treating mesothelioma and lung cancer and practices at the Cleveland Clinic in Cleveland, Ohio.
